Page last updated: 2024-08-18

pyrroles and Addiction, Opioid

pyrroles has been researched along with Addiction, Opioid in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cador, M; Koob, GF; Stinus, L; Zorrilla, EP1
Chen, J; Chi, ZQ; Ju, YW; Li, QL; Liu, JG; Long, YQ; Tao, YM; Xu, XJ; Zhang, CF1
Capasso, A1
Ceng, X; Huang, M; Lu, L1

Other Studies

4 other study(ies) available for pyrroles and Addiction, Opioid

ArticleYear
Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2005, Volume: 30, Issue:1

    Topics: Acamprosate; Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Avoidance Learning; Buprenorphine; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Implants; Fluoxetine; Lisuride; Male; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Substance Withdrawal Syndrome; Taurine

2005
LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    European journal of pharmacology, 2008, Apr-28, Volume: 584, Issue:2-3

    Topics: Acetic Acid; Analgesics, Opioid; Animals; Behavior, Animal; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Hot Temperature; Humans; Male; Mice; Motor Activity; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Pain; Pain Measurement; Pain Threshold; Protein Binding; Pyrroles; Rats; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Time Factors; Transfection

2008
Further studies on the involvement of the arachidonic acid cascade in the acute dependence produced by mu, kappa and delta opioid agonists in isolated tissues.
    Neuropharmacology, 1999, Volume: 38, Issue:6

    Topics: Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Benzeneacetamides; Cyclooxygenase 1; Cyclooxygenase 2; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Enzyme Inhibitors; Guinea Pigs; Ileum; In Vitro Techniques; Isoenzymes; Jejunum; Male; Oligopeptides; Opioid-Related Disorders; Phospholipases A; Phospholipases A2; Prostaglandin-Endoperoxide Synthases; Pyrroles; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu

1999
Corticotropin-releasing factor receptor type I mediates stress-induced relapse to opiate dependence in rats.
    Neuroreport, 2000, Aug-03, Volume: 11, Issue:11

    Topics: Animals; Behavior, Animal; Conditioning, Psychological; Corticotropin-Releasing Hormone; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Male; Morphine; Neuropsychological Tests; Opioid-Related Disorders; Psychomotor Performance; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Secondary Prevention; Stress, Physiological

2000